SONOMA PHARMACEUTICALS, INC. Proceeds from Long-Term Debt Issued
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Proceeds from Long-Term Debt Issued of $1.31 million for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-02-16
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-06-30 was $1.31M.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2012 was $2.50M, a 16.67% decline from fiscal 2011.
- SONOMA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2011 was $3.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $1.31M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | $1.31M 10-Q · filed 2020-11-20 | ||
| 2020-06-30 | $1.31M 10-Q/A · filed 2020-11-17 | |||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | |
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | $0.00 10-Q · filed 2020-11-20 | ||
| 2019-06-30 | $0.00 10-Q/A · filed 2020-11-17 | |||
| 2013-03-31 | $0.00 10-K · filed 2013-06-25 | |||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | |||
| 2012-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $1.00M derived: sum of 2 quarters · filed 2013-06-25 | $1.00M derived: sum of 3 quarters · filed 2013-06-25 | $2.50M 10-K · filed 2013-06-25 |
| 2011-12-31 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | $1.00M derived: sum of 2 quarters · filed 2013-02-13 | $2.50M 10-Q · filed 2013-02-13 | $2.50M derived: sum of 4 quarters · filed 2013-02-13 |
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08 | $1.50M 10-Q · filed 2012-11-08 | $1.50M derived: sum of 3 quarters · filed 2012-11-08 | $2.50M derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | $1.50M 10-Q/A · filed 2012-08-31 | $1.50M derived: sum of 2 quarters · filed 2012-08-31 | $2.50M derived: sum of 3 quarters · filed 2012-08-31 | $2.50M derived: sum of 4 quarters · filed 2012-08-31 |
| 2011-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $1.00M derived: sum of 2 quarters · filed 2012-06-21 | $1.00M derived: sum of 3 quarters · filed 2012-06-21 | $3.00M 10-K · filed 2012-06-21 |
| 2010-12-31 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-10 | $1.00M derived: sum of 2 quarters · filed 2012-02-10 | $3.00M 10-Q · filed 2012-02-10 | |
| 2010-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-11-03 | $2.00M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $2.00M 10-Q/A · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |